These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31027430)

  • 1. Central Line-Associated Bloodstream Infections in Children With Hematologic and Oncologic Diseases: First Prevalence Results From a University Hospital.
    Özalp Gerçeker G; Yardımcı F; Aydınok Y
    J Pediatr Oncol Nurs; 2019; 36(5):327-336. PubMed ID: 31027430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of central line bundles on the timing of catheter-associated bloodstream infections and their microbiological distribution in critically ill children.
    Devrim İ; Sandal OS; Çelebi MY; Hepduman P; Gönüllü A; Atakul G; Kara AA; Oruç Y; Gülfidan G; Bayram N; Ağın H
    Eur J Pediatr; 2023 Oct; 182(10):4625-4632. PubMed ID: 37555974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central venous catheter-associated bloodstream infections in pediatric hematology-oncology patients and effectiveness of antimicrobial lock therapy.
    Tsai HC; Huang LM; Chang LY; Lee PI; Chen JM; Shao PL; Hsueh PR; Sheng WH; Chang YC; Lu CY
    J Microbiol Immunol Infect; 2015 Dec; 48(6):639-46. PubMed ID: 25311403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of central line-associated bloodstream infections in a pediatric hematology/oncology population.
    Wilson MZ; Deeter D; Rafferty C; Comito MM; Hollenbeak CS
    Am J Med Qual; 2014; 29(6):484-90. PubMed ID: 24226650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Risk of Central Line-associated Bloodstream Infections in Pediatric Hematology/Oncology Patients.
    Kristinsdottir I; Haraldsson A; Gudlaugsson O; Thors V
    Pediatr Infect Dis J; 2021 Sep; 40(9):827-831. PubMed ID: 33990520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Characteristics and Risk Factors of Long-term Central Venous Catheter-associated Bloodstream Infections in Children.
    Moon HM; Kim S; Yun KW; Kim HY; Jung SE; Choi EH; Lee HJ
    Pediatr Infect Dis J; 2018 May; 37(5):401-406. PubMed ID: 29194165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for central line-associated bloodstream infection in pediatric oncology patients with a totally implantable venous access port: A cohort study.
    Viana Taveira MR; Lima LS; de Araújo CC; de Mello MJ
    Pediatr Blood Cancer; 2017 Feb; 64(2):336-342. PubMed ID: 27666952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duration of central venous catheter placement and central line-associated bloodstream infections after the adoption of prevention bundles: a two-year retrospective study.
    Pitiriga V; Bakalis J; Kampos E; Kanellopoulos P; Saroglou G; Tsakris A
    Antimicrob Resist Infect Control; 2022 Jul; 11(1):96. PubMed ID: 35841083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a Best Practice Prevention Bundle on Central Line-associated Bloodstream Infection (CLABSI) Rates and Outcomes in Pediatric Hematology, Oncology, and Hematopoietic Cell Transplantation Patients in Inpatient and Ambulatory Settings.
    Ardura MI; Bibart MJ; Mayer LC; Guinipero T; Stanek J; Olshefski RS; Auletta JJ
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e64-e72. PubMed ID: 32960848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of Pediatric Central Venous Access Device Placement With Concomitant Surgical Procedures.
    Bludevich BM; Chandler NM; Gonzalez R; Danielson PD; Snyder CW
    J Surg Res; 2021 Mar; 259():451-457. PubMed ID: 33616076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central Line Associated Blood Stream Infections in Pediatric Hematology/Oncology Patients With Different Types of Central Lines.
    Hord JD; Lawlor J; Werner E; Billett AL; Bundy DG; Winkle C; Gaur AH;
    Pediatr Blood Cancer; 2016 Sep; 63(9):1603-7. PubMed ID: 27198806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons learned from a hospital-wide review of blood stream infections for paediatric central line-associated blood stream infection prevention.
    Campbell AJ; Blyth CC; Hewison CJ; Chen YP; Gough L; Goff Z; Bowen AC
    J Paediatr Child Health; 2019 Jun; 55(6):690-694. PubMed ID: 30315622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reducing ambulatory central line-associated bloodstream infections: A family-centered approach.
    Wong CI; Ilowite M; Yan A; Mahan RM; Desrochers MD; Conway M; Billett AL
    Pediatr Blood Cancer; 2024 Aug; 71(8):e31064. PubMed ID: 38761026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing CLABSIs among pediatric hematology/oncology inpatients: national collaborative results.
    Bundy DG; Gaur AH; Billett AL; He B; Colantuoni EA; Miller MR;
    Pediatrics; 2014 Dec; 134(6):e1678-85. PubMed ID: 25404721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in Central Line-Associated Bloodstream Infection Rates Among Children With Immune Compromised Conditions: An 11-Year Review.
    Linder LA; Gerdy C; Jo Y; Wilson A
    J Pediatr Oncol Nurs; 2018; 35(6):382-391. PubMed ID: 29665727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of mucosal barrier injury laboratory-confirmed bloodstream infection (MBI-LCBI) on central line-associated bloodstream infections (CLABSIs) in department of hematology at single university hospital in Japan.
    Kato Y; Hagihara M; Kurumiya A; Takahashi T; Sakata M; Shibata Y; Kato H; Shiota A; Watanabe H; Asai N; Koizumi Y; Yamagishi Y; Mikamo H
    J Infect Chemother; 2018 Jan; 24(1):31-35. PubMed ID: 29066217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central line-associated bloodstream infection in childhood malignancy: Single-center experience.
    Miliaraki M; Katzilakis N; Chranioti I; Stratigaki M; Koutsaki M; Psarrou M; Athanasopoulos E; Stiakaki E
    Pediatr Int; 2017 Jul; 59(7):769-775. PubMed ID: 28376269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central-line-associated bloodstream infections in a pediatric oncology and hematology hospital at home program.
    Raimbault SC; Domenech C; Fuhrmann C; Bertrand A
    Infect Control Hosp Epidemiol; 2023 May; 44(5):780-785. PubMed ID: 35912672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenging the 48-Hour Rule-Out for Central Line-Associated Bloodstream Infections in the Pediatric Intestinal Failure Population: A Retrospective Pilot Study.
    Chang MI; Carlson SJ; Nandivada P; O'Loughlin AA; Potemkin AK; Cowan E; Mitchell PD; Gura KM; Puder M
    JPEN J Parenter Enteral Nutr; 2016 May; 40(4):567-73. PubMed ID: 25567785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripherally inserted central catheters are associated with lower risk of bloodstream infection compared with central venous catheters in paediatric intensive care patients: a propensity-adjusted analysis.
    Yamaguchi RS; Noritomi DT; Degaspare NV; Muñoz GOC; Porto APM; Costa SF; Ranzani OT
    Intensive Care Med; 2017 Aug; 43(8):1097-1104. PubMed ID: 28584925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.